Celldex Therapeutics, Inc.
CLDX
$22.19
$0.210.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.27% | 71.22% | 221.23% | 217.50% | 195.94% |
| Total Receivables | -60.16% | -73.36% | 238.10% | 1,200.00% | 103.27% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 120.30% | 287.38% | 112.82% | -32.33% | -11.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.95% | 73.08% | 216.69% | 206.61% | 188.44% |
|
|
|||||
| Total Current Assets | -16.95% | 73.08% | 216.69% | 206.61% | 188.44% |
| Net Property, Plant & Equipment | 30.34% | 24.21% | 5.32% | -12.23% | -18.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9,628.04% | 9,009.35% | 9,009.35% | 0.00% | 2.88% |
| Total Assets | -14.89% | 70.17% | 193.72% | 182.51% | 167.73% |
|
|
|||||
| Total Accounts Payable | 5.44% | -6.55% | -68.93% | 331.56% | -4.15% |
| Total Accrued Expenses | 45.16% | 53.62% | 52.69% | 51.70% | 87.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -8.82% | -10.04% | -10.86% | 3.86% | 10.11% |
| Total Finance Division Other Current Liabilities | -57.36% | -76.38% | -67.01% | 275.56% | 296.42% |
| Total Other Current Liabilities | -57.36% | -76.38% | -67.01% | 275.56% | 296.42% |
| Total Current Liabilities | 21.78% | 26.91% | 15.29% | 76.77% | 72.75% |
|
|
|||||
| Total Current Liabilities | 21.78% | 26.91% | 15.29% | 76.77% | 72.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 310.43% | 154.42% | 31.49% | -53.86% | -78.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -26.78% | -21.12% | -21.12% | -21.12% | -21.12% |
| Total Liabilities | 20.69% | 24.36% | 11.14% | 46.63% | 38.82% |
|
|
|||||
| Common Stock & APIC | 1.85% | 26.09% | 43.17% | 43.15% | 42.92% |
| Retained Earnings | -12.51% | -11.30% | -11.38% | -11.42% | -11.27% |
| Treasury Stock & Other | 59.00% | 0.18% | 147.68% | -14.09% | 5.70% |
| Total Common Equity | -16.17% | 74.06% | 218.54% | 193.17% | 177.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.17% | 74.06% | 218.54% | 193.17% | 177.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.17% | 74.06% | 218.54% | 193.17% | 177.01% |
|
|
|||||